severe obesity
Conditions
Interventions
Glucose clamp tests are performed before bariatric surgery and 6 months after surgery.
Sponsors
Tottori University Faculty of Medicine, Division of Cardiovascular Medicine and Endocrinology and Me
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing obesity reduction surgery who obtained consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who violate any of the following are excluded from this study. 1) Diabetes patients with etiology other than type 2 diabetes 2) Patients with a history of severe ketosis, diabetic coma or precoma within the past 6 months. 3) Patients with severe infections and serious trauma 4) Pregnant women or women who may be pregnant and breast-feeding patients 5) Patients with severe liver dysfunction 6) Patients with moderate or higher renal dysfunction or end-stage renal failure on dialysis 7) Patients with heart failure (NYHA classification II-IV) 8) Patients with serious mental illness 9) Patients with a history of hypersensitivity to insulin 10) Obese patients due to abnormal endocrine hormones 11) Patients treated with steroid hormones 12) Patients who are not suitable for study participation because of medical reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To examine changes in insulin resistance index by glucose clamp test before and after bariatric surgery. | — |
Countries
Japan
Contacts
Public ContactTsuyoshi Okura
Tottori University Faculty of Medicine Division of Cardiovascular Medicine and Endocrinology and Metabolism
Outcome results
None listed